Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 9Leukemia, Myeloid, Acute 9Carcinoma, Renal Cell 7Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 5Prostatic Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Pancreatic Neoplasms 3Melanoma 3Hematopoietic and Lymphatic System Neoplasm 3Glioblastoma 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Anatomic Stage I Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Sleep Initiation and Maintenance Disorders 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms 1

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 1Hepatectomy 1Blood Specimen Collection 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Fibrosis × Specimen Handling × Clear all
NCT07042919 2025-06-29

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Northwestern University

Phase 1/2 Not yet recruiting
53 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡